Thomas H. Kean, U.S. Representative

Thomas H. Kean

RepublicanNJ07houseFiled May 15, 2025
View all of Thomas H. Kean's trades →36 total filings on record

Thomas H. Kean (R-NJ) bought $1K-$15K of $AMZN (Amazon.com, Inc. - Common Stock (AMZN) [ST]) on Apr 24, 2025, part of 11 transactions in this filing (9 buys, 2 sells).

HillSignal flagged 5 timing concerns on this filing — trades that line up closely with related legislative or contract activity.

Transactions
11
Companies
10
Largest Trade
$1K-$15K
Timing Flags
5

Price Movement Since Trade

How the largest positions have moved from the trade date to the most recent close.

$ADI✓ GOOD CALL
Information Technology
Trade Day
$195.23
Apr 24, 2025
Current
$399.57
Apr 24, 2026
Change
+104.67%
+$204.34
Transportation & Logistics

Showing the 6 largest positions. See every transaction in the table below.

Suspicious Timing Detected

5 flags
1.

Thomas H. Kean bought $1,001 - $15,000 in $ILMN on 2025-04-01, 6 days before HR2678 ("Ellie’s Law") was introduced, a bill directing funding for unruptured intracranial aneurysm research.

2.

Thomas H. Kean bought $1,001 - $15,000 in $ILMN on 2025-04-01, 8 days before HR2767 ("BRAIN Act") was introduced, aiming to increase research and awareness for brain tumor treatment.

3.

Thomas H. Kean bought $1,001 - $15,000 in $AMZN on 2025-04-24, 28 days before S1918 ("Access Technology Affordability Act of 2025") was introduced, which proposes a tax credit for access technology purchases.

4.

Thomas H. Kean bought $1,001 - $15,000 in $AMZN and PLD on 2025-04-24, 49 days before S2056 ("CREATE JOBS Act") was introduced, proposing to reinstate 100% bonus depreciation.

5.

Thomas H. Kean bought $1,001 - $15,000 in $ILMN on 2025-04-01, 113 days before HR4752 ("Reducing Hereditary Cancer Act") was introduced, mandating Medicare coverage for germline mutation testing.

These flags identify timing coincidences between stock trades and legislative activity. They do not imply wrongdoing. Click any bill number or ticker to see the full analysis.

Share This Filing

All Transactions

BUY$1K-$15K
$AMZNAmazon.com, Inc. - Common Stock (AMZN) [ST]
$186.54 \u2192 N/A
Apr 24, 2025 \u2022 self
BUY$1K-$15K
$ADIAnalog Devices, Inc. - Common Stock (ADI) [ST]
$195.23 \u2192 $399.57+104.7%
Apr 24, 2025 \u2022 self
BUY$1K-$15K
$CPCanadian Pacific Kansas City Limited Common Shares (CP) [ST]
$71.21 \u2192 N/A
Apr 10, 2025 \u2022 self
BUY$1K-$15K
$FCNCAFirst Citizens BancShares, Inc. - Class A Common Stock (FCNCA) [ST]
$1,639.64 \u2192 N/A
Apr 10, 2025 \u2022 self
BUY$1K-$15K
$FCNCAFirst Citizens BancShares, Inc. - Class A Common Stock (FCNCA) [ST]
$1,639.64 \u2192 N/A
Apr 11, 2025 \u2022 self
BUY$1K-$15K
$FIFiserv, Inc. Common Stock (FI) [ST]
$176.90 \u2192 N/A
Apr 24, 2025 \u2022 self
BUY$1K-$15K
$ILMNIllumina, Inc. - Common Stock (ILMN) [ST]
$78.39 \u2192 N/A
Apr 1, 2025 \u2022 self
BUY$1K-$15K
$NVTnVent Electric plc Ordinary Shares (NVT) [ST]
$53.22 \u2192 N/A
Apr 1, 2025 \u2022 self
BUY$1K-$15K
$PLDPrologis, Inc. Common Stock (PLD) [ST]
$103.36 \u2192 N/A
Apr 24, 2025 \u2022 self
SELL$1K-$15K
$FTVFortive Corporation Common Stock (FTV) [ST]
Apr 10, 2025 \u2022 self

Connected Legislative Activity

10 signals

These bills and contracts share tickers or sectors with this filing's trades.

BillHR3491neutral

DeOndra Dixon INCLUDE Project Act of 2025

HR3491 (DeOndra Dixon INCLUDE Project Act) authorizes a Down syndrome research program at NIH but appropriates zero funding. With only 5 procedural actions over a year and stalled committee markup, the bill has no near-term market impact. No public companies are directly affected.

May 21, 2026
BillS2056bullish

CREATE JOBS Act

The CREATE JOBS Act (S.2056) proposes permanently reinstating 100% bonus depreciation for all U.S. businesses, a proven tax incentive reducing the after-tax cost of capital equipment by 21% in year one. At current market prices, capital-intensive companies like CAT ($810.05), DE ($560.02), FDX ($388.59), and AMZN ($263.04) have already shown strong 30-day momentum (CAT +21.37%, FDX +13.7%, AMZN +30.9%), reflecting broader economic expectations this tax policy reinforces. The bill is in early committee stage with legislative risk high, but identical House companion HR3967 improves odds of eventual enactment.

Jun 12, 2025
AMZNCATDEFDXGEVPLD
BillHR4032bearish

Lowering Broadband Costs for Consumers Act of 2025

HR4032 (Lowering Broadband Costs for Consumers Act) is an early-stage bill that would expand USF contribution requirements to broadband and edge providers. It remains in committee with no floor action, making near-term market impact negligible. If passed, $CMCSA, $T, $VZ, $GOOGL, $META, $AMZN, and $NFLX would face new recurring costs reducing segment margins by an estimated 1-3%.

Jun 17, 2025
AMZNCMCSAGOOGLMETANFLXT
BillHR2678bullish

Ellie’s Law

Ellie's Law (HR2678) is an early-stage authorization bill directing NINDS to research unruptured intracranial aneurysms. It authorizes zero dollars, has no funding appropriation, and has only been referred to committee. Market impact is negligible in the near term for device and research tool providers like MDT, TMO, ILMN, and DGX, as no actual spending exists and the legislative path is years from completion.

Apr 7, 2025
MDT
BillHR4528bearish

Price Gouging Prevention Act of 2025

The Price Gouging Prevention Act of 2025 (HR4528) is an early-stage House bill capping corporate margins during 'exceptional market shocks'. Currently referred to committee with zero appropriations, the bill poses a structural long-term regulatory risk to all large-cap companies with pricing flexibility, particularly retailers ($WMT, $AMZN) and integrated energy ($XOM, $CVX). Near-term market impact is low given early legislative stage, but the bill's breadth — covering all goods and services — represents a significant expansion of FTC authority if it advances.

Jul 17, 2025
AMZNCVXJNJPFETSLAWMT
BillS1918neutral

Access Technology Affordability Act of 2025

S. 1918 is an early-stage, low-probability bill proposing a refundable tax credit for blind individuals purchasing access technology. It creates no direct revenue stream for any public company and has negligible near-term market impact.

May 22, 2025
BillHR2767neutral

BRAIN Act

The BRAIN Act (HR2767) is an early-stage bill in the 119th Congress that authorizes no funding and has been referred to committee. Near-term market impact is negligible. The bill creates programmatic structures for brain tumor research, biospecimen transparency, and biomarker testing awareness, but actual market effects require future appropriations and bill text clarity. No publicly traded companies face material revenue exposure at this stage.

Apr 9, 2025
BillS1829bearish

STOP CSAM Act of 2025

The STOP CSAM Act (S.1829) has advanced to the Senate calendar, increasing passage probability. The bill mandates elevated content moderation and reporting requirements for major tech and telecom companies, directly increasing compliance costs. Affected tickers include $META, $GOOGL, $MSFT, $AMZN, $VZ, $T, and $TWLO. Market data shows strong recent rallies in tech stocks ($GOOGL +27.95%, $META +24.75%, $AMZN +30.9% over 30 days), creating potential downside risk if compliance cost headwinds materialize.

Jun 26, 2025
GOOGLMETAMSFTTTWLOVZ
BillS1875neutral

Streamlining Federal Cybersecurity Regulations Act of 2025

S.1875 is an early-stage procedural bill to create an interagency committee for harmonizing federal cybersecurity regulations. It contains no funding, no mandates, and no procurement directives. Near-term market impact is negligible.

May 22, 2025
CRWDPANW
Billneutral

IGNITEACTION LLC: $16.1M Department of Commerce Contract

This $16.1 million contract to IGNITEACTION LLC for cloud infrastructure support at the U.S. Census Bureau represents a steady demand for IT modernization services, likely benefiting major cloud providers and IT consulting firms. While IGNITEACTION is private, this award signals continued federal investment in cloud migration, a positive trend for the broader technology sector.

May 30, 2025
AMZNAVGOCSCOGOOGLMSFTORCL

Other Filings by Thomas H. Kean

Free — no credit card

Get the next Kean trade the day it's disclosed

HillSignal tracks every Congressional stock filing and federal contract, scores its market impact with AI, and emails you the ones that matter — before they hit the news.

Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.

Free forever plan · No credit card · Unsubscribe in one click

Want the live terminal too? Create a free account →

Data sourced from the U.S. House of Representatives Office of the Clerk Financial Disclosure system. Stock prices from Financial Modeling Prep. Suspicious timing flags identify coincidences between stock trades and legislative activity and do not imply any wrongdoing or illegal activity. This is not financial advice.